Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg for Small Fiber Neuropathy
NCT02637700Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2016
- Primary completion
- Mar 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous human immunoglobulin in small fiber neuropathy (SFN), sponsored by Maastricht University Medical Center+. Started Jul 2016; status: completed.
02
Drugs
intravenous human immunoglobulin
03
Conditions
small fiber neuropathy (SFN)
Beyond the preview
Go deeper on NCT02637700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02637700.